- Home
- Results news
- Deep Health AI India
- Q2 FY27 results
Deep Health AI India Q2 FY27 results: net profit down 91.7% to ₹0.21 crore, revenue down 86.6%
Deep Health AI India Limited reported consolidated revenue of ₹0.45 crore and a net profit of ₹0.21 crore for Q2 FY27. Revenue was lower than Q2 FY26, while profit recovered from the loss reported in Q1 FY27.
Key points
- Consolidated revenue was ₹0.45 crore in Q2 FY27, down from ₹3.35 crore in Q2 FY26.
- EBITDA was ₹0.20 crore, with a margin of 44.4%, against a margin of 96.4% in Q2 FY26.
- Net profit was ₹0.21 crore and basic EPS was ₹0.01, compared with a net profit of ₹2.53 crore and EPS of ₹0.54 in Q2 FY26.
- In H1 FY27, revenue was ₹0.90 crore and the company reported a net loss of ₹1.94 crore, against revenue of ₹3.50 crore and a net profit of ₹2.60 crore in H1 FY26.
- Cash fell to ₹4.01 crore at 30 September 2026 from ₹8.34 crore at 31 March 2026, while H1 FY27 operating cash flow was negative ₹3.71 crore.
How did Deep Health AI India perform in Q2 FY27?
Deep Health AI India reported consolidated revenue of ₹0.45 crore for Q2 FY27, compared with ₹3.35 crore in Q2 FY26. EBITDA was ₹0.20 crore and margin was 44.4%, against ₹3.23 crore and 96.4% a year earlier. The company reported a net profit of ₹0.21 crore and basic EPS of ₹0.01.
Against Q1 FY27, revenue was unchanged at ₹0.45 crore, while total income rose to ₹0.64 crore from ₹0.62 crore. EBITDA moved from a loss of ₹2.06 crore to a profit of ₹0.20 crore, and net profit moved from a loss of ₹2.15 crore to a profit of ₹0.21 crore. The standalone figures were revenue of ₹0.45 crore and a net profit of ₹0.27 crore.
| ₹ crore | Q2 FY27 | Q1 FY27 | Q2 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 0.45 | 0.45 | 3.35 | −86.6% | +0.0% |
| Other income | 0.19 | 0.17 | 0.16 | +18.8% | +11.8% |
| Total expenses | 0.26 | 2.52 | 0.13 | +100.0% | −89.7% |
| EBITDA | 0.20 | −2.06 | 3.23 | −93.8% | turned to profit |
| EBITDA margin | 44.4% | -457.1% | 96.4% | −52.0 pp | +501.5 pp |
| Profit before tax | 0.33 | −1.90 | 3.38 | −90.2% | turned to profit |
| Tax | 0.12 | 0 | 0.85 | −85.9% | |
| Net profit | 0.21 | −2.15 | 2.53 | −91.7% | turned to profit |
| EPS (₹) | 0.01 | 0.15 | 0.54 | −98.1% | −93.3% |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in Deep Health AI India's costs and profit?
Total expenses increased to ₹0.26 crore from ₹0.13 crore in Q2 FY26. Other expenses rose to ₹0.20 crore from ₹0.08 crore, while employee costs increased to ₹0.05 crore from ₹0.04 crore; finance costs were ₹0.01 crore in both quarters. Other income rose to ₹0.19 crore from ₹0.16 crore.
Profit before tax fell to ₹0.33 crore from ₹3.38 crore in Q2 FY26. Tax expense declined to ₹0.12 crore from ₹0.85 crore, but the result included a ₹0.06 crore exceptional charge. The net profit was ₹0.21 crore, compared with ₹2.53 crore in the year-ago quarter.
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 0 | 0 | 0 | |
| Employee cost | 0.05 | 0.04 | +0.01 | +25.0% |
| Finance costs | 0.01 | 0.01 | 0 | +0.0% |
| Depreciation | 0 | 0 | 0 | |
| Other expenses | 0.20 | 0.08 | +0.12 | +150.0% |
| Total expenses | 0.26 | 0.13 | +0.13 | +100.0% |
| Other income | 0.19 | 0.16 | +0.03 | +18.8% |
| Tax | 0.12 | 0.85 | −0.73 | −85.9% |
| Exceptional items | −0.06 (charge) | none |
Source: Company's results filing (XBRL).
How did the first half of FY27 go?
In the first half of FY27, Deep Health AI India reported consolidated revenue of ₹0.90 crore, total income of ₹1.26 crore and a net loss of ₹1.94 crore. Profit before tax was a loss of ₹1.82 crore and basic EPS was negative ₹0.13.
Revenue fell from ₹3.50 crore in H1 FY26 and total income fell from ₹3.84 crore. The company moved from a profit before tax of ₹3.48 crore and a net profit of ₹2.60 crore in H1 FY26 to losses of ₹1.82 crore and ₹1.94 crore, respectively. Basic EPS declined from ₹0.54 to negative ₹0.13.
| ₹ crore | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 0.90 | 3.50 | −74.3% |
| Profit before tax | −1.82 | 3.48 | turned to loss |
| Net profit | −1.94 | 2.60 | turned to loss |
| EPS (₹) | −0.13 | 0.54 |
Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
At 30 September 2026, total assets were ₹54.03 crore and total equity was ₹53.19 crore, compared with ₹52.08 crore and ₹51.37 crore at 31 March 2026. Borrowings were ₹0.39 crore against ₹0.37 crore, while cash fell to ₹4.01 crore from ₹8.34 crore. Inventories were ₹0.51 crore, trade receivables were ₹0.45 crore and trade payables were ₹0.32 crore.
H1 FY27 operating cash flow was negative ₹3.71 crore, compared with negative ₹0.38 crore in H1 FY26. Investing cash flow was negative ₹0.61 crore against positive ₹0.37 crore a year earlier, while financing cash flow was negative ₹0.0 crore against ₹0.0 crore.
| ₹ crore | As of 30 September 2026 | As of 31 March 2026 |
|---|---|---|
| Total assets | 54.03 | 52.08 |
| Total equity | 53.19 | 51.37 |
| Borrowings | 0.39 | 0.37 |
| Cash and equivalents | 4.01 | 8.34 |
| Inventories | 0.51 | 0.51 |
| Trade receivables | 0.45 | 2.92 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 | H1 FY26 |
|---|---|---|
| Cash from operations | −3.71 | −0.38 |
| Cash from investing | −0.61 | 0.37 |
| Cash from financing | 0 | 0 |
| Capital expenditure | 0 | 0 |
Source: Company's results filing (XBRL).
How has Deep Health AI India done over the last 8 quarters?
Revenue reached a peak of ₹3.35 crore in Q2 FY26 and was ₹0.45 crore in the latest quarter. Net profit peaked at ₹3.04 crore in Q3 FY26 and bottomed at a loss of ₹4.51 crore in Q4 FY26, before recovering to ₹0.21 crore in Q2 FY27. EBITDA margin improved to 44.4% from negative 457.1% in Q1 FY27, after reaching 96.4% in Q2 FY26.
Which businesses drove the quarter?
The Pharmaceutical Business reported revenue of ₹0.45 crore in Q2 FY27, down from ₹3.35 crore in the year-ago quarter, with EBIT of ₹0.20 crore against ₹3.23 crore. Revenue declined 86.6%, and the segment’s EBIT margin was 44.1%.
The Jewellery Business reported revenue of ₹0.00 crore and EBIT of ₹0.00 crore, unchanged from Q2 FY26. Other Income contributed EBIT of ₹0.19 crore, compared with ₹0.16 crore in the year-ago quarter, while revenue remained ₹0.00 crore.
| Segment | Revenue | Revenue YoY | EBIT | EBIT margin |
|---|---|---|---|---|
| Jewellery Business | 0 | 0 | ||
| Pharmaceutical Business | 0.45 | −86.6% | 0.20 | 44.1% |
| Other Income | 0 | 0.19 |
Source: Company's results filing (XBRL segment data).
How did Deep Health AI India shares react?
The filing appeared after market hours from a base price of ₹1.64. The stock was unchanged in the first five minutes, then fell 1.2% after 15 minutes and 30 minutes. It closed unchanged on the reaction day and was up 1.2% by the next day’s close from its pre-results close; no five-day move was available.
The industry median rose 0.8% on the reaction day and 1.7% by the next day’s close, while Deep Health AI India’s excess performance was negative 0.8 percentage points on the reaction day and negative 0.5 percentage points by the next day’s close. Earlier results-day moves were 0.0% on 13 July 2026, negative 0.9% on 30 May 2026, negative 4.8% on 11 February 2026 and 8.5% on 7 October 2025.
| After the filing | Stock | Gems, Jewellery And Watches median |
|---|---|---|
| 5 minutes | +0.0% | |
| 15 minutes | −1.2% | |
| 30 minutes | −1.2% | |
| Reaction day | +0.0% | +0.8% |
| Next day | +1.2% | +1.7% |
Minutes are measured from the price when the filing appeared; days from the previous close. Source: MarketPing price-reaction measurement.
| Results filed on | Stock on the reaction day |
|---|---|
| 13 July 2026 | +0.0% |
| 30 May 2026 | −0.9% |
| 11 February 2026 | −4.8% |
| 7 October 2025 | +8.5% |
| 13 August 2025 | −1.2% |
| 29 May 2025 | −2.7% |
| 14 August 2024 | −7.6% |
| 24 May 2024 | +0.8% |
Source: MarketPing price-reaction measurement.
How did other Gems, Jewellery And Watches companies do?
Sixteen other Gems, Jewellery And Watches companies had filed for the quarter, with a median revenue growth of 21.1%. All 16 grew faster than Deep Health AI India, while none grew slower. Nine of the 17 companies compared for profit reported higher profit.
| Deep Health AI India revenue growth (YoY) | −86.6% |
|---|---|
| Median of 16 other Gems, Jewellery And Watches companies | +21.1% |
| Companies with slower revenue growth than Deep Health AI India | 0 of 16 |
| Companies with faster revenue growth than Deep Health AI India | 16 of 16 |
| Companies whose net profit rose | 9 of 17 |
Source: Filed results (XBRL) of the industry's companies.
Quick answers
What was Deep Health AI India's revenue in Q2 FY27?
Revenue from operations was ₹0.45 crore, down 86.6% from ₹3.35 crore in Q2 FY26 (consolidated).
Did Deep Health AI India make a profit in Q2 FY27?
Yes. Net profit was ₹0.21 crore, against a net profit of ₹2.53 crore in Q2 FY26.
What was Deep Health AI India's EPS in Q2 FY27?
Basic earnings per share were ₹0.01, against ₹0.54 in Q2 FY26.
How did Deep Health AI India shares react to the Q2 FY27 results?
On the reaction day the stock moved +0.0% from the previous close; the median Gems, Jewellery And Watches stock moved +0.8%.
When did Deep Health AI India announce its Q2 FY27 results?
On 3 November 2026, in a filing to the BSE.
Sources
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.